The results highlighted NFIL3's participation in several cancer-related pathways, including transcriptional misregulation in cancer, the p53 signaling pathway, pancreatic cancer, the FoxO signaling pathway, apoptosis, and the MAPK signaling pathway, among others. The gene discussed is TP53; the disease is familial pancreatic carcinoma.